Calviri

Let’s End Cancer – First in Dogs, Then People

Print
Follow Claim My Business
Form C
View on StartEngine
Min Investment
$499
Location
Phoenix, AZ
Expected Close Date
November 21, 2024
Target Raise
$10.00K-$1.23M
Security Price
$3.22
Website
calviri.com
Number of Employees
24
Cash
$349,758
Revenue
$21,661
Short Term Debt
$294,581
Cost of Goods
$0
Long Term Debt
$0
Net Income
$-5,540,651

Company Description

Calviri is a pre-revenue, pre-market biotech company that has built a vaccine to PREVENT cancer in dogs – NOT ONLY TREAT IT. Our vaccine prevents cancer from starting in the first place.
Amount Raised : $126,759
Reveal the Score by Voting
＿
0
ⓘ
Business Idea
ⓘ
Business Traction
ⓘ
Management Team
ⓘ
Valuation

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment